RHEUMATOID ARTHRITIS

This study looked at whether using a smartphone app and a handgrip device could help people with rheumatoid arthritis manage their condition with fewer in-person doctor visits. About 94 adults with active rheumatoid arthritis were planned to take part. The study was stopped early…

This study followed 61 people who received a Cadence Total Ankle System to replace a damaged ankle joint due to arthritis. The goal was to see how long the implant lasts and how well patients move and feel over time. The study was ended early, but the data collected helps doctors…

This study tested a drug called peresolimab in adults with moderate to severe rheumatoid arthritis, a condition causing joint pain and swelling. The goal was to see if the drug safely improves symptoms like tender and swollen joints. The trial was stopped early, but results may s…

This study in Colombia looked at whether a smart injection device (Smartclic) helps people with rheumatoid arthritis stick to their etanercept medication. Researchers reviewed medical records of 60 patients over 40 weeks to track how often they used the device and how their sympt…

This study tested whether adding a 12-week course of VIB4920 to standard TNF-inhibitor therapy could improve disease control in people with rheumatoid arthritis who did not respond well to TNF-inhibitors alone. Only 2 participants were enrolled before the study was stopped. The g…

This study tested whether a new drug called IHL-675A could safely reduce pain and improve daily function in people with rheumatoid arthritis. The trial planned to enroll 128 adults, but was stopped early with only 20 participants. Participants would have taken the drug twice dail…

This study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body handles a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on the same treatments. The goal was t…

This study looked at special immune cells called regulatory T cells in the joint fluid of people with rheumatoid arthritis during a flare-up. The goal was to understand how these cells behave in the inflamed joint compared to the blood. 19 adults with active arthritis took part. …

This study aimed to understand how age influences serious health issues like infections, cancer, heart disease, and fractures in people with rheumatoid arthritis. Researchers planned to compare older patients (over 65) with younger adults. The study was stopped early, so results …

This study aimed to see if pairing rheumatoid arthritis patients for one-on-one support could improve their daily function and medication habits. Researchers planned to enroll 65 adults with RA to measure changes in health and well-being. The study was terminated early, so result…

This study looked at whether small fluid-filled sacs between the foot bones, called intermetatarsal bursitis, cause pain in people with rheumatoid arthritis. Only 3 patients were enrolled before the study ended early. Researchers used MRI and ultrasound to find these sacs and tra…

This study looked at how two common pain relievers—celecoxib (a Coxib) and naproxen (an NSAID)—affect blood clotting in people with rheumatoid arthritis who also take daily aspirin for heart health. Eight adults with arthritis and increased heart risk took each pain reliever for …

This study looked at whether JAK inhibitors, a type of drug, can increase the number of anti-inflammatory B cells in people with rheumatoid arthritis. Researchers tested this in lab experiments using blood samples from 27 patients. The goal was to understand how these drugs affec…

This early-stage study tested a new radioactive drug called [11C]MC1 to see if it could help PET scans show inflammation in the body. Researchers studied healthy volunteers and people with rheumatoid arthritis or inflammatory muscle disease. The study was stopped early, but the g…